- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Hypercholesterolaemia
- Meeting Date: March 2020
- Public Summary Document (PSD) March 2020 PBAC Meeting - (PDF 831KB)
- Public Summary Document (PSD) March 2020 PBAC Meeting - (Word 167KB)
Alirocumab – March 2020
Alirocumab: Injection 75 mg in 1 ml single dose pre-filled pen injection 150 mg in 1 ml single dose pre-filled pen; Praluent®
Last updated
3 July 2020